A retrospective claims analysis on rates of compliance and discontinuation among Canadian multiple sclerosis patients treated with disease-modifying therapies at 6, 12 and 24-month periods

Authors
Category Primary study
JournalValue in Health
Year 2017
This article has no abstract
Epistemonikos ID: 33b8fdc2ca4743bd35227466759e6ec91fb0b04b
First added on: Feb 08, 2025